Brief: Landos Biopharma Reports Q2 2022 Results
11/08/2022 15:00
Aug 11 (Reuters) - Landos Biopharma Inc LABP.O :
* LANDOS BIOPHARMA REPORTS SECOND QUARTER 2022 RESULTS AND
PROVIDES BUSINESS UPDATE
* LANDOS BIOPHARMA INC - AS OF JUNE 30, 2022, COMPANY HAD
CASH,
CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $55.8 MILLION
* LANDOS BIOPHARMA INC - QTRLY NET LOSS PER SHARE, BASIC AND
DILUTED $0.28
Source text for Eikon: ID:nGNX5HTyKx
Further company coverage: LABP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Landos Biopharma
See all newsLandos Biopharma Inc expected to post a loss of 100 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma